September 10, 2024
For the Record- September 10, 2024: DCTI, Guidance on Research Involving VA
In this Issue:
Draft Diversity Plan and Associated Guidance
Reminder
As announced in our special August 16, 2024 newsletter, the HSD has developed a new SUPPLEMENT Diversity Plan for Clinical Trials and associated guidance to assist researchers in complying with the requirements of RCW 69.78 (WA State’s new Diversity in Clinical Trials law).
The draft Supplement and associated guidance are posted on our website for public comment through September 16, 2024. Feedback may be embedded as comments and/or tracked changes within the Word document or in whatever method you prefer. Please send all feedback to hsdinfo@uw.edu.
September 4th DCTI Town Hall
Recording Now Available
Thank you to everyone who participated in our virtual town hall on September 4, 2024, regarding the UW’s Diversity in Clinical Trials Initiative. At this event we presented an overview of the draft SUPPLEMENT Diversity Plan for Clinical Trials and associated guidance followed by a Q&A session with attendees. A recording of the event is now available along with a complete list of the questions and answers.
Upcoming September 20th DCTI Town Hall
Register
Registration for the September 20, 2024 (2:00-3:30pm Pacific Time), virtual town hall meeting regarding the UW’s Diversity in Clinical Trials Initiative is now open. This event is intended to provide researchers and other interested parties with information about translation/interpreter services and community engagement resources that are being put in place to support researcher compliance with WA State’s new Diversity in Clinical Trials law (RCW 69.78).
The event will begin with a 30-minute overview presentation, followed by a 60-minute Q&A. Attendees are encouraged to submit in advance any questions they would like addressed using the Contact Us form on the UW DCTI website. For those unable to attend, a post-session recording will be available.
Guidance on Research Involving Veterans Affairs
Update
HSD has compiled and expanded its guidance on research involving the U.S. Department of Veterans Affairs (VA), which includes VA Puget Sound Healthcare System (VAPSHCS). This new, easier to find guidance, was developed in consultation with individuals at VAPSHCS and the VA’s Office of Research Development.
Only one significant change has been made to HSD’s policies about VA research: UW individuals who have an official Without Compensation (WOC) status at any VA entity are no longer also considered agents of the UW for the purpose of the research that the WOC applies to. If the UW’s only involvement in the research is a UW affiliated individual working under a WOC, the UW will no longer be considered engaged in the research and dual review from both a VA IRB and the UW IRB is not required.
Investigators planning research involving any VA entity should review the guidance and contact HSD’s Reliance Team at hsdrely@uw.edu with any questions.